JP2008543874A5 - - Google Patents

Download PDF

Info

Publication number
JP2008543874A5
JP2008543874A5 JP2008517192A JP2008517192A JP2008543874A5 JP 2008543874 A5 JP2008543874 A5 JP 2008543874A5 JP 2008517192 A JP2008517192 A JP 2008517192A JP 2008517192 A JP2008517192 A JP 2008517192A JP 2008543874 A5 JP2008543874 A5 JP 2008543874A5
Authority
JP
Japan
Prior art keywords
compound
formula
acyl
protecting group
oxygen protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008517192A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008543874A (ja
JP5159616B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/023668 external-priority patent/WO2006138673A2/en
Publication of JP2008543874A publication Critical patent/JP2008543874A/ja
Publication of JP2008543874A5 publication Critical patent/JP2008543874A5/ja
Application granted granted Critical
Publication of JP5159616B2 publication Critical patent/JP5159616B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008517192A 2005-06-15 2006-06-15 アミノシクロヘキシルエーテル化合物の調製のための合成プロセス Active JP5159616B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69098905P 2005-06-15 2005-06-15
US60/690,989 2005-06-15
US74824805P 2005-12-07 2005-12-07
US60/748,248 2005-12-07
PCT/US2006/023668 WO2006138673A2 (en) 2005-06-15 2006-06-15 Synthetic processes for the preparation of aminocyclohexyl ether compounds

Publications (3)

Publication Number Publication Date
JP2008543874A JP2008543874A (ja) 2008-12-04
JP2008543874A5 true JP2008543874A5 (enExample) 2012-02-23
JP5159616B2 JP5159616B2 (ja) 2013-03-06

Family

ID=37395936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008517192A Active JP5159616B2 (ja) 2005-06-15 2006-06-15 アミノシクロヘキシルエーテル化合物の調製のための合成プロセス

Country Status (7)

Country Link
US (4) US7754897B2 (enExample)
EP (1) EP1915340B1 (enExample)
JP (1) JP5159616B2 (enExample)
BR (1) BRPI0612138B8 (enExample)
CA (1) CA2612375C (enExample)
MX (2) MX346530B (enExample)
WO (1) WO2006138673A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4991037B2 (ja) * 2004-04-01 2012-08-01 カーディオム ファーマ コーポレイション イオンチャネル調節化合物を含む薬物結合体
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
JP5159314B2 (ja) * 2004-11-18 2013-03-06 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物の合成方法
BRPI0612138B8 (pt) 2005-06-15 2021-05-25 Cardiome Pharma Corp compostos éter aminocicloexílicos e método para fazer os mesmos
WO2008137778A2 (en) * 2007-05-04 2008-11-13 Cardiome Pharma Corp. Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
EP2445504A4 (en) * 2009-06-23 2012-11-14 Medicinova Inc 2-AMINO-1- (2-ISOPROPYLPYRAZOLO [1,5-A] PYRIDINE-3-YL) PROPAN-1-ONE ENANTIOMER COMPOSITIONS AND METHODS THEREOF
CA2808098C (en) 2010-08-16 2020-03-10 Merck Sharp & Dohme Corp. Process for preparing aminocyclohexyl ether compounds
WO2012024104A2 (en) 2010-08-16 2012-02-23 Codexis, Inc. Biocatalysts and methods for the synthesis of (1r,2r)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine
CN110711188A (zh) 2012-01-20 2020-01-21 德玛公司 经取代的己糖醇类用于治疗恶性肿瘤的用途
US20150087687A1 (en) 2012-03-23 2015-03-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
AU2013280644B2 (en) 2012-06-26 2018-08-02 Jeffrey A. BACHA Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or AHI1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
JP2016519684A (ja) 2013-04-08 2016-07-07 デニス エム ブラウン 準最適に投与された薬物療法の有効性を改善するための及び/又は副作用を低減するための方法および組成物
WO2015154064A2 (en) 2014-04-04 2015-10-08 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
IL314380A (en) 2016-10-06 2024-09-01 Orbus Therapeutics Inc Preparations for administration of aflornithine
EP3615053A4 (en) 2017-04-25 2021-07-14 Temple Otorongo LLC PHARMACEUTICAL COMPOSITION CONSISTING OF TRYPTOPHAN AND A PHYLLOKININ DERIVATIVE FOR USE IN THE TREATMENT OF PSYCHIATRIC AND PSYCHOLOGICAL DISORDERS

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA710830A (en) 1965-06-01 Moser Paul Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
DE2860703D1 (en) 1977-12-01 1981-08-20 Bayer Ag Benzyl ethers of cyclic 1,2-diols, methods for their preparation and their use as herbicides
DE2753556A1 (de) 1977-12-01 1979-06-07 Bayer Ag Benzylaether von cyclischen 1,2-diolen, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
US4684728A (en) 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
EP0317780B1 (en) 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
DE3836917A1 (de) 1988-10-29 1990-05-17 Bayer Ag Verfahren zur herstellung von cyclopropylamin
US5215919A (en) 1991-02-25 1993-06-01 Takeda Chemical Industries, Ltd. Process for producing optically active 2-hydroxycycloalkanecarboxylic acid esters using microbially derived reductase
JP3696884B2 (ja) 1994-03-25 2005-09-21 アイソテクニカ、インコーポレーテッド ジュウテリウム化による薬物の効能の増強
ES2176429T3 (es) 1995-02-03 2002-12-01 Basf Ag Disociacion de racementos de aminas primarias y secundarias substituidas por hteroatomos mediante acilado catalizado por via enzimatica.
DE19523868A1 (de) 1995-06-30 1997-01-02 Huels Chemische Werke Ag Verfahren zur Herstellung von Cyclopropanamin
AU735900B2 (en) 1996-03-12 2001-07-19 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
US6441025B2 (en) 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6342507B1 (en) 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
DE69840586D1 (de) 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
CZ302147B6 (cs) 1998-04-01 2010-11-18 Nortran Pharmaceuticals Inc. Aminocyklohexyletherová sloucenina, použití této slouceniny pri výrobe léciva, farmaceutická kompozice tuto slouceninu obsahující a tato sloucenina a kompozice pro použití pri lécení
US6264975B1 (en) 1998-10-20 2001-07-24 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000051981A1 (en) 1999-03-04 2000-09-08 Nortran Pharmaceuticals Inc. Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
CA2311483A1 (en) 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
KR20030017569A (ko) * 2000-06-28 2003-03-03 테바 파마슈티컬 인더스트리즈 리미티드 카르베딜올
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
EP1291336A3 (en) 2001-09-05 2003-10-08 Solvias AG Preparation of optically active alpha-hydroxyethers
JP2003250577A (ja) 2001-12-27 2003-09-09 Sumitomo Chem Co Ltd 2‐ヒドロキシシクロアルカンカルボン酸エステルの製造方法
AU2003248647A1 (en) 2002-06-14 2003-12-31 Johnson Matthey Pharmaceutical Materials, Inc. Stereoselective synthesis of 1,2-disubstituted cycloalkyls
AU2003267540A1 (en) 2002-08-13 2004-02-25 Sirus Pharmaceuticals Ltd Biodegradable polymer
US7056540B2 (en) 2002-10-29 2006-06-06 Council Of Scientific And Industrial Research Enzymatic process for the preparation of optically active alcohols from ketones using tuberous root Daucus carota
BR122018009866B8 (pt) 2003-05-02 2021-07-27 Cardiome Pharma Corp métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
CA2524034A1 (en) 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
WO2005016242A2 (en) 2003-06-04 2005-02-24 Cardiome Pharma Corp. Synthetic process for trans-aminocyclohexyl ether compounds
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
CA2561819A1 (en) * 2004-04-01 2005-12-01 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
JP4991037B2 (ja) * 2004-04-01 2012-08-01 カーディオム ファーマ コーポレイション イオンチャネル調節化合物を含む薬物結合体
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
JP5159314B2 (ja) 2004-11-18 2013-03-06 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物の合成方法
BRPI0612138B8 (pt) 2005-06-15 2021-05-25 Cardiome Pharma Corp compostos éter aminocicloexílicos e método para fazer os mesmos
US20090069404A1 (en) 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched vernakalant

Similar Documents

Publication Publication Date Title
JP2008543874A5 (enExample)
TWI681961B (zh) (6S,9aS)-N-苄基-6-[(4-羥基苯基)甲基]-4,7-二氧-8-({6-[3-(哌-1-基)四氫吖唉-1-基]吡啶-2-基}甲基)-2-(丙-2-烯-1-基)-八氫-1H-吡并[2,1-c][1,2,4]三-1-甲醯胺化合物
CN102803254B (zh) 用于软海绵素b类似物合成的呋喃并[3,2-b]吡喃衍生物
JP2013518116A5 (enExample)
JP2019537559A5 (enExample)
FI95027B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-substituoitujen pyrrolidiinijohdannaisten valmistamiseksi
JP2008512379A5 (enExample)
JP2012510502A5 (enExample)
JP2013505259A5 (enExample)
JP2005519083A5 (enExample)
CN1157615A (zh) 杂环速激肽受体拮抗物
JP2010532340A5 (enExample)
WO2005002293A3 (en) Cox-2-targeted imaging agents
JP2008545700A5 (enExample)
JP2009543792A5 (enExample)
JP2007531766A5 (enExample)
JP2009040767A5 (enExample)
JP2002526527A5 (enExample)
JP2016540793A5 (enExample)
JP7136527B2 (ja) 3-[(3s)-7-ブロモ-2-オキソ-5-(ピリジン-2-イル)-2,3-ジヒドロ-1h-[1,4]-ベンゾジアゼピン-3-イル]プロピオン酸メチルエステルの調製方法及びその方法に有用な化合物
JP2017535566A5 (enExample)
JP2008509113A5 (enExample)
JP2007500203A5 (enExample)
JP2010516779A5 (enExample)
ES2433135T3 (es) Compuestos biciclicos de tetrahidropirrol